project id: TCGA-HNSC; case submitter id: TCGA-CN-A6V1; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.6; rna integrity number: 8.6; age at index: 59; days to birth: -21730; ethnicity: not reported; gender: male; race: white; vital status: Alive; year of birth: 1954; age at diagnosis: 21730; ajcc clinical m: M0; ajcc clinical n: N2b; ajcc clinical stage: Stage IVA; ajcc clinical t: T2; ajcc pathologic m: MX; ajcc pathologic n: N2a; ajcc pathologic stage: Stage IVA; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 603.0; icd 10 code: C09.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Tonsil, NOS; synchronous malignancy: Yes; tissue or organ of origin: Tonsil, NOS; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: No; is ffpe: false; composition: Not Reported; days to collection: 141; initial weight: 170.0; oct embedded: false; preservation method: Unknown; sample id: b2ad9679-048c-43c4-9d78-45638ad5a493; sample submitter id: TCGA-CN-A6V1-01A; portion id: aeff360a-3032-41c2-9ae1-cab2c85282c1; portion submitter id: TCGA-CN-A6V1-01A-12; slide id: e2e428a4-cca8-4837-ba3c-921b3fa977f1; slide submitter id: TCGA-CN-A6V1-01A-01-TS1; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 75.0; section location: TOP;